FI20086158A0 - Imidatsopyridiinijohdannaiset - Google Patents

Imidatsopyridiinijohdannaiset

Info

Publication number
FI20086158A0
FI20086158A0 FI20086158A FI20086158A FI20086158A0 FI 20086158 A0 FI20086158 A0 FI 20086158A0 FI 20086158 A FI20086158 A FI 20086158A FI 20086158 A FI20086158 A FI 20086158A FI 20086158 A0 FI20086158 A0 FI 20086158A0
Authority
FI
Finland
Prior art keywords
imidazopyridine
Prior art date
Application number
FI20086158A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Mikael Dahlstroem
Original Assignee
Mikael Dahlstroem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mikael Dahlstroem filed Critical Mikael Dahlstroem
Priority to FI20086158A priority Critical patent/FI20086158A0/fi
Publication of FI20086158A0 publication Critical patent/FI20086158A0/fi
Priority to ES09748823T priority patent/ES2415894T3/es
Priority to EP09748823A priority patent/EP2365975B1/en
Priority to JP2011539063A priority patent/JP5702295B2/ja
Priority to US13/132,564 priority patent/US8669269B2/en
Priority to AU2009324007A priority patent/AU2009324007B2/en
Priority to DK09748823.3T priority patent/DK2365975T3/da
Priority to CA2744647A priority patent/CA2744647C/en
Priority to BRPI0916475A priority patent/BRPI0916475A2/pt
Priority to MX2011005769A priority patent/MX2011005769A/es
Priority to CN200980148444.7A priority patent/CN102239167B/zh
Priority to PT97488233T priority patent/PT2365975E/pt
Priority to PCT/FI2009/050861 priority patent/WO2010063876A1/en
Priority to SI200930616T priority patent/SI2365975T1/sl
Priority to KR1020117015341A priority patent/KR101742328B1/ko
Priority to PL09748823T priority patent/PL2365975T3/pl
Priority to RU2011124169/04A priority patent/RU2509771C2/ru
Priority to IL213242A priority patent/IL213242A/en
Priority to ZA2011/04838A priority patent/ZA201104838B/en
Priority to HK12104485.0A priority patent/HK1164277A1/xx
Priority to HRP20130476AT priority patent/HRP20130476T1/hr
Priority to CY20131100442T priority patent/CY1114038T1/el
Priority to SM201300066T priority patent/SMT201300066B/xx
Priority to US14/183,852 priority patent/US8993589B2/en
Priority to JP2014246949A priority patent/JP2015063548A/ja

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI20086158A 2008-12-03 2008-12-03 Imidatsopyridiinijohdannaiset FI20086158A0 (fi)

Priority Applications (25)

Application Number Priority Date Filing Date Title
FI20086158A FI20086158A0 (fi) 2008-12-03 2008-12-03 Imidatsopyridiinijohdannaiset
RU2011124169/04A RU2509771C2 (ru) 2008-12-03 2009-10-27 Производные имидазопиридина, ингибирующие секрецию кислоты желудочного сока
CN200980148444.7A CN102239167B (zh) 2008-12-03 2009-10-27 抑制胃酸分泌的咪唑并吡啶衍生物
PCT/FI2009/050861 WO2010063876A1 (en) 2008-12-03 2009-10-27 Imidazopyridine derivatives which inhibit the secretion of gastric acid
JP2011539063A JP5702295B2 (ja) 2008-12-03 2009-10-27 胃酸の分泌を抑制するイミダゾピリジン誘導体
US13/132,564 US8669269B2 (en) 2008-12-03 2009-10-27 Imidazopyridine derivatives which inhibit the secretion of gastric acid
AU2009324007A AU2009324007B2 (en) 2008-12-03 2009-10-27 Imidazopyridine derivatives which inhibit the secretion of gastric acid
DK09748823.3T DK2365975T3 (da) 2008-12-03 2009-10-27 Imidazopyridinderivativer, som inhiberer secernering af mavesyre
CA2744647A CA2744647C (en) 2008-12-03 2009-10-27 Imidazopyridine derivatives which inhibit the secretion of gastric acid
BRPI0916475A BRPI0916475A2 (pt) 2008-12-03 2009-10-27 imidazo[1,2-a]piridina substituída, de fórmula i ou um sal farmaceuticamente aceitável da mesma, processo para a preparação da imidazo[1,2-a]piridina substituída, composição farmacêutica, e, uso da imidazo[1,2-a]piridina substituída
MX2011005769A MX2011005769A (es) 2008-12-03 2009-10-27 Derivados de imidazopiridina que inhiben la secrecion del acido gastrico.
ES09748823T ES2415894T3 (es) 2008-12-03 2009-10-27 Derivados de imidazopiridinas que inhiben la secreción de ácido gástrico
PT97488233T PT2365975E (pt) 2008-12-03 2009-10-27 Derivados de imidazopiridina que inibem a secreção do ácido gástrico
EP09748823A EP2365975B1 (en) 2008-12-03 2009-10-27 Imidazopyridine derivatives which inhibit the secretion of gastric acid
SI200930616T SI2365975T1 (sl) 2008-12-03 2009-10-27 Derivati imidazopiridina, ki inhibirajo izloček želodčne kisline
KR1020117015341A KR101742328B1 (ko) 2008-12-03 2009-10-27 위산의 분비를 억제하는 이미다조피리딘 유도체
PL09748823T PL2365975T3 (pl) 2008-12-03 2009-10-27 Pochodne imidazopirydyny, które hamują wydzielanie kwasu żołądkowego
IL213242A IL213242A (en) 2008-12-03 2011-05-31 History of imidazopyridine inhibiting gastric acid secretion
ZA2011/04838A ZA201104838B (en) 2008-12-03 2011-06-30 Imidazopyridine derivatives which inhibit the secretion of gastric acid
HK12104485.0A HK1164277A1 (en) 2008-12-03 2012-05-08 Imidazopyridine derivatives which inhibit the secretion of gastric acid
HRP20130476AT HRP20130476T1 (hr) 2008-12-03 2013-05-29 Derivati imidazopiridina koji inhibiraju sekreciju želuäśane kiseline
CY20131100442T CY1114038T1 (el) 2008-12-03 2013-06-04 Παραγωγα ιμιδαζοπυριδινης τα οποια αναστελλουν την εκκριση γαστρικου οξεος
SM201300066T SMT201300066B (it) 2008-12-03 2013-06-19 Derivati di imidazopiridina che inibiscono la secrezione di succo gastrico
US14/183,852 US8993589B2 (en) 2008-12-03 2014-02-19 Imidazopyridine derivatives which inhibit the secretion of gastric acid
JP2014246949A JP2015063548A (ja) 2008-12-03 2014-12-05 胃酸の分泌を抑制するイミダゾピリジン誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20086158A FI20086158A0 (fi) 2008-12-03 2008-12-03 Imidatsopyridiinijohdannaiset

Publications (1)

Publication Number Publication Date
FI20086158A0 true FI20086158A0 (fi) 2008-12-03

Family

ID=40240558

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20086158A FI20086158A0 (fi) 2008-12-03 2008-12-03 Imidatsopyridiinijohdannaiset

Country Status (23)

Country Link
US (2) US8669269B2 (pt)
EP (1) EP2365975B1 (pt)
JP (2) JP5702295B2 (pt)
KR (1) KR101742328B1 (pt)
CN (1) CN102239167B (pt)
AU (1) AU2009324007B2 (pt)
BR (1) BRPI0916475A2 (pt)
CA (1) CA2744647C (pt)
CY (1) CY1114038T1 (pt)
DK (1) DK2365975T3 (pt)
ES (1) ES2415894T3 (pt)
FI (1) FI20086158A0 (pt)
HK (1) HK1164277A1 (pt)
HR (1) HRP20130476T1 (pt)
IL (1) IL213242A (pt)
MX (1) MX2011005769A (pt)
PL (1) PL2365975T3 (pt)
PT (1) PT2365975E (pt)
RU (1) RU2509771C2 (pt)
SI (1) SI2365975T1 (pt)
SM (1) SMT201300066B (pt)
WO (1) WO2010063876A1 (pt)
ZA (1) ZA201104838B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20086158A0 (fi) * 2008-12-03 2008-12-03 Mikael Dahlstroem Imidatsopyridiinijohdannaiset
CN106279151A (zh) * 2015-06-26 2017-01-04 江苏太瑞生诺生物医药科技有限公司 5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法
KR101777971B1 (ko) * 2016-07-05 2017-09-12 제일약품주식회사 이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이의 용도
KR20220097431A (ko) 2019-11-04 2022-07-07 싱클루스 파마 홀딩 에이비 X842의 경구용 제제
WO2023079093A1 (en) 2021-11-05 2023-05-11 Cinclus Pharma Holding AB (publ) Polymorphs of the mesylate salt of linaprazan glurate
CN118201927A (zh) 2021-11-05 2024-06-14 辛克鲁斯制药控股有限公司(Publ) 戊二酸利那拉赞的盐酸盐的多晶型物
WO2023184282A1 (en) 2022-03-30 2023-10-05 Guizhou Sinorda Biomedicine Co., Ltd X842 formulation
KR102496869B1 (ko) * 2022-07-29 2023-02-07 제일약품주식회사 이미다조[1,2-a]피리딘 화합물의 신규 염, 이의 결정형 및 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE0003186D0 (sv) 2000-09-07 2000-09-07 Astrazeneca Ab New process
SE0102808D0 (sv) 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
SE0301905D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound I with therapeutic effect
SE0301903D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound III with therapeutic effect
EP1974730A1 (en) * 2003-11-03 2008-10-01 AstraZeneca AB Imidazo[1,2-a]pyridine derivatives for use in the treatment of sleep disturbance due to silent gastro-esophageal reflux
SE0303451D0 (sv) 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
TW200700064A (en) 2005-03-24 2007-01-01 Glaxo Group Ltd Novel compounds
WO2007039464A1 (en) 2005-09-22 2007-04-12 Nycomed Gmbh Isotopically substituted imidazopyridine derivatives for the treatment of gastrointestinal disorders
FI20086158A0 (fi) * 2008-12-03 2008-12-03 Mikael Dahlstroem Imidatsopyridiinijohdannaiset

Also Published As

Publication number Publication date
US20110237619A1 (en) 2011-09-29
MX2011005769A (es) 2011-09-15
IL213242A0 (en) 2011-07-31
IL213242A (en) 2014-01-30
US8993589B2 (en) 2015-03-31
CA2744647A1 (en) 2010-06-10
AU2009324007A1 (en) 2011-07-07
SI2365975T1 (sl) 2013-08-30
CN102239167A (zh) 2011-11-09
CA2744647C (en) 2018-01-09
PL2365975T3 (pl) 2013-08-30
BRPI0916475A2 (pt) 2019-09-10
HK1164277A1 (en) 2012-09-21
HRP20130476T1 (hr) 2013-08-31
JP2015063548A (ja) 2015-04-09
SMT201300066B (it) 2013-09-06
KR101742328B1 (ko) 2017-06-01
RU2011124169A (ru) 2013-01-10
EP2365975B1 (en) 2013-03-13
ES2415894T3 (es) 2013-07-29
CY1114038T1 (el) 2016-07-27
ZA201104838B (en) 2012-03-28
JP5702295B2 (ja) 2015-04-15
US8669269B2 (en) 2014-03-11
PT2365975E (pt) 2013-06-20
AU2009324007B2 (en) 2014-05-08
KR20110096146A (ko) 2011-08-29
CN102239167B (zh) 2015-06-17
DK2365975T3 (da) 2013-06-10
EP2365975A1 (en) 2011-09-21
RU2509771C2 (ru) 2014-03-20
JP2012510505A (ja) 2012-05-10
WO2010063876A1 (en) 2010-06-10
US20140235666A1 (en) 2014-08-21

Similar Documents

Publication Publication Date Title
NL301058I2 (nl) Brolucizumab
DK2376490T3 (da) Imidazopyridinforbindelser
BRPI0914657A2 (pt) piridin-2-onae piridazin-3-onas substituídas
DK2370462T3 (da) Glucagon-analoger
BRPI0907376A2 (pt) Fotobiorretador
DK2342317T3 (da) Hængende-dråbe-plade
DE602009000234D1 (de) msignals
DK3444343T3 (da) Polypeptider
BRPI0914649A2 (pt) Piprazolo-quinazolinas
DE602008003972D1 (de) Sitzrücklehnungsmechanismus
DE602008003521D1 (de) Sitzrücklehnungsmechanismus
DK2336132T3 (da) Morpholinpurinderivat
DK2342454T3 (da) Vindkraftanlæg
DK2335031T3 (da) In-line-måler
DK2379557T3 (da) Aminopyrazol-forbindelse
DE602008003970D1 (de) Strahlstromkalibriersystem
DK2271613T3 (da) Hydroxymethylcyklohexylaminer
BRPI0907522A2 (pt) biarlamidas
BRPI0909634A2 (pt) 2-aminoquinolinas
DE112009001946A5 (de) Mobelauszugsführung
DE602009000488D1 (de) Obstvereinzelvorrichtung
BRPI0907863A2 (pt) pirrolopirimidinacarboxamidas
BRPI0909637A2 (pt) 2-aminoquinolinas
DE112009000183A5 (de) Sicherheitsvorreiber
FI20086158A0 (fi) Imidatsopyridiinijohdannaiset

Legal Events

Date Code Title Description
FD Application lapsed